Stay updated on Atezolizumab with BCG in NMIBC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.

Latest updates to the Atezolizumab with BCG in NMIBC Clinical Trial page
- Check4 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedA banner announces NIH’s terminology transition, noting that “Super Intelligence” (SI) may appear in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check17 days agoChange DetectedThe footer’s site revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the usual study content, indicating an access restriction to the study record.SummaryDifference20%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a minor update to the page’s metadata.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab with BCG in NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.